博九娱乐网

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development and commercialization of products focused on addressing medication abuse and misuse, utilizing its Aversion and Impede Technologies. The Company鈥檚 product, Oxecta Tablets CII (Oxecta) represents the immediate-release oxycodone product approved by the United States Food and Drug Administration…More that applies its Aversion Technology. Aversion is a mixture of inactive ingredients incorporated into pharmaceutical tablets and capsules designed to address some common methods of product tampering associated with abuse. As of December 31, 2011, the Company was also developing Nexafed, an over-the-counter (OTC) immediate-release pseudoephedrine HCl tablet, utilizing its Impede Technology. On January 23, 2012, Oxecta was made commercially available by Pfizer Inc. (Pfizer). On June 17, 2011, Oxecta was approved for marketing by the United States Food and Drug Administration.